Researchers discover the mTOR pathway is highly active in many cases of pediatric low-grade glioma. Blocking the pathway lead to a decreased growth of the brain tumors.
Exposure to radiation appears to increase the risk of developing meningioma brain cancer in people under the age of 30, a new study reports.
New research shows the transmembrane protein NG2 controls orientation of cell migration towards a wound.
Researchers have developed a new approach that uses microRNA in combination with chemotherapy to help treat glioblastoma brain cancer. In preclinical models, the approach increases survival of the deadly brain cancer five fold.
Researchers demonstrate melanoma differentiation associated gene, mda-9/syntenin is a driving force behind the aggressive and invasive nature of glioblastoma brain cancer.
Researchers have shown that infrared and Raman spectroscopy – coupled with statistical analysis – can be used to tell the difference between normal brain tissue and the different tumor types that may arise in this tissue, based on its individual biochemical-cell ‘fingerprint’.
A new probe developed uses an innovative fluorescence-reading technology to help brain surgeons distinguish cancerous tissue from normal tissue. The probe tool, now already in use at the Cancer Center for brain surgery, may one day be used for surgeries for a variety of cancers.
According to a new study, a drug currently used to treat advanced skin cancer has also shown to be effective against the SHH subtype of Medulloblastoma brain cancer.
Researchers discover the genetic landscape of the most common form of brain tumor can be explained by abnormalities in five genes. The finding could help to develop personalized medical therapies and treatment options.
A new study could pave the way for more effective treatment of infantile ETMR/ETANTR brain cancer.